CYP24A1 and Hypercalcemia: Infants suffering from this disorder display severe hypercalcaemia and suppressed PTH levels due to their severely impaired capacity to catabolise 25(OH)D and 1,25(OH)2D, as a result of an inactivating mutation in the gene coding for CYP24A1 [45,46].